Biopharmaceutical

With world-class expertise in ctDNA analysis including both targeted panel and personalized panel approaches, Inivata is committed to partnering with pharmaceutical and biotech companies to accelerate clinical research to aid in the development of oncology focused therapies and to improve patient outcomes.

One leading liquid biopsy platform – multiple applications

InVision Custom - Custom Liquid Biopsy panels applicable to other cancer types
  • Specifically designed for liquid biopsy
  • Optimized for high sensitivity
  • Robust customizable approach
InVisionFirst Lung and InVisionSeq logos
  • 37 gene panel for advanced NSCLC
  • SNVs, Indels, CNV and fusions
  • CAP/CLIA Lab
  • Medicare Reimbursed test
  • Turnaround time within 7 days calendar days
InVision Custom - Custom Liquid Biopsy panels applicable to other cancer types
  • Personalized assay: Multi-Tumor
  • 48 markers derived from tissue analysis
  • Turnaround time within 7 calendar days for monitoring
  • Sensitivity:  10ppm / 0.001VAF%

We are partnering with organizations that share our vision to transform the lives of cancer patients through the power of liquid biopsy.

Please contact us to find out more.

Our Technology

Our Solutions

Latest News